Name:
Afipia clevelandensis Brenner et al. 1992
DSM No.:
7315, Type strain
Strain designation:
411m, B91-007353, F6703, G1849
Other collection no.
or WDCM no.:
ATCC 49720,Cleveland clinic foundation strain
Isolated from:
human tibia, biopsy
Country:
United States of America
Ohio
Date of sampling:
before 04.11.1992
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- ATCC <- D.J. Brenner; B91-007353 <- G.S. Hall
Cultivation conditions:
Medium 585 , 28°C
Complete DSMZ Media List
Summary and
additional information:
<- ATCC <- D.J. Brenner; B91-007353 <- G.S. Hall. [Cleveland clinic foundation strain]. Human tibia, biopsy; USA, Ohio. Type strain. Taxonomy/description (4535, 4869). Ubiquinone Q-10 (4870). (Medium 585, 28°C)
Literature:
4535, 4869, 4870
Risk group:
2 (classification according to German TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1
Supplied as:
Delivery form Prices
Price Category for this culture: 1
Freight and handling charges will be added. See price list.
Note: Freight charges for Risk Group 2 microorganisms will apply.
Afipia clevelandensis 信息由北京百欧博伟生物技术有限公司为您提供,如您想了解更多关于 Afipia clevelandensis 报价、型号、参数等信息,欢迎来电或留言咨询。除供应 Afipia clevelandensis 外,北京百欧博伟生物技术有限公司还可为您提供 Pseudoalteromonas atlantica、 Aeromonas caviae、 Treponema caldarium 等产品,公司有专业的客户服务团队,是您值得信赖的合作伙伴。